ArticleClinical and experimental nephrology2018

Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism.

Takashi Shigematsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.